Medicated Skin Care in Ukraine

May 2012 | 37 pages | ID: MA75B77D5CCEN
Euromonitor International Ltd

Abstracts

In 2011, medicated skin care registered current value growth of 12%, below the review period CAGR of 14%, to UAH453 million. Even though Ukrainians became less economical in 2011, another year of relative economic stabilisation, sales were driven largely by rising prices. Higher manufacturing and logistics costs were passed on to consumers. Consumers regularly self-medicate and tend to buy advertised products (usually more expensive than generics), which also contributes to value over volume...

Euromonitor International's Medicated Skin Care in Ukraine report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Medicated Skin Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 6 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Borschahivsky Khfz Nvts Zat in Consumer Health (ukraine)
Strategic Direction
Key Facts
  Summary 1 Borschahivsky KhFZ NVTs ZAT: Key Facts
  Summary 2 Borschahivsky KhFZ NVTs ZAT: Operational Indicators
Company Background
Production
  Summary 3 Borschahivsky KhFZ NVTs ZAT: Production Statistics 4th Quarter 2011
Competitive Positioning
  Summary 4 Borschahivsky KhFZ NVTs ZAT: Competitive Position 2011
Darnitsa Ff Zat in Consumer Health (ukraine)
Strategic Direction
Key Facts
  Summary 5 Darnitsa FF ZAT: Key Facts
  Summary 6 Darnitsa FF ZAT: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 7 Darnitsa FF ZAT: Competitive Position 2011
Farmak Vat in Consumer Health (ukraine)
Strategic Direction
Key Facts
  Summary 8 Farmak VAT: Key Facts
  Summary 9 Farmak VAT: Operational Indicators
Company Background
Production
  Summary 10 Farmak VAT: Production Statistics 2009
Competitive Positioning
  Summary 11 Farmak VAT: Competitive Position 2011
Vitaminy Vat in Consumer Health (ukraine)
Strategic Direction
Key Facts
  Summary 12 Vitaminy VAT: Key Facts
  Summary 13 Vitaminy VAT: Operational Indicators
Company Background
Production
  Summary 14 Vitaminy VAT: Production Statistics 2010
Competitive Positioning
  Summary 15 Vitaminy VAT: Competitive Position 2011
Executive Summary
Consumer Health Resilient To Crisis
Rx Medicines Sold Without Prescriptions Press OTC Offers Still
Global Crisis Added To Local Manufacturers' Competitiveness in Ukraine
Chemists/pharmacies Still the Largest Distribution Channel
Consumer Health Performance in Future Depends on Government's Initiatives
Key Trends and Developments
Economic Hazards Restrict Consumer Health's Potential
Preventative Medication Revives and Boosts Vds Sales
Widespread Self-medication Contributes To OTC Sales
Fake Medicines Still A Headache for Ukrainian Healthcare
Local Manufacturers Gain Competitiveness
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 8 Life Expectancy at Birth 2006-2011
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2006-2011
  Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 11 Consumer Health Company Shares 2007-2011
  Table 12 Consumer Health Brand Shares 2008-2011
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 16 OTC -Switches 2009-2011
Definitions
Sources
  Summary 17 Research Sources